Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B).
Phosphodiesterase-4 (PDE4), an enzyme that catalyzes the hydrolysis of cyclic AMP and plays a critical role in controlling its intracellular concentration, has been implicated in depression- and anxiety-like behaviors. However, the functions of the four PDE4 subfamilies (PDE4A, PDE4B, PDE4C, and PDE4D) remain largely unknown. In animal tests sensitive to anxiolytics, antidepressants, memory enhancers, or analgesics, we examined the behavioral phenotype of mice deficient in PDE4B (PDE4B-/-). Immunoblot analysis revealed loss of PDE4B expression in the cerebral cortex and amygdala of PDE4B-/- mice. The reduction of PDE4B expression was accompanied by decreases in PDE4 activity in the brain regions of PDE4B-/- mice. Compared to PDE4B+/+ littermates, PDE4B-/- mice displayed anxiogenic-like behavior, as evidenced by decreased head-dips and time spent in head-dipping in the holeboard test, reduced transitions and time on the light side in the light-dark transition test, and decreased initial exploration and rears in the open-field test. Consistent with anxiogenic-like behavior, PDE4B-/- mice displayed increased levels of plasma corticosterone. In addition, these mice also showed a modest increase in the proliferation of neuronal cells in the hippocampal dentate gyrus. In the forced-swim test, PDE4B-/- mice exhibited decreased immobility; however, this was not supported by the results from the tail-suspension test. PDE4B-/- mice did not display changes in memory, locomotor activity, or nociceptive responses. Taken together, these results suggest that the PDE4B subfamily is involved in signaling pathways that contribute to anxiogenic-like effects on behavior.
Zhang
Han-Ting
HT
Department of Behavioral Medicine and Psychiatry, West Virginia University Health Sciences Center, Morgantown, WV 26506, USA. hzhang@hsc.wvu.edu
Huang
Ying
Y
Masood
Anbrin
A
Stolinski
Lisa R
LR
Li
Yunfeng
Y
Zhang
Lei
L
Dlaboga
Daniel
D
Jin
S-L Catherine
SL
Conti
Marco
M
O'Donnell
James M
JM
D000704:Analysis of Variance; D000818:Animals; D001007:Anxiety / Q000097:blood / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology*; D001362:Avoidance Learning; D001522:Behavior, Animal; D001921:Brain / Q000473:pathology / Q000503:physiopathology; D001973:Bromodeoxyuridine / Q000378:metabolism; D049109:Cell Proliferation; D003345:Corticosterone / Q000097:blood; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4 / Q000172:deficiency* / Q000378:metabolism; D004195:Disease Models, Animal; D005106:Exploratory Behavior; D005786:Gene Expression Regulation / Q000502:physiology; D019417:Hindlimb Suspension; D008297:Male; D008568:Memory; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009043:Motor Activity; D010641:Phenotype; D011930:Reaction Time
D054703:Cyclic Nucleotide Phosphodiesterases, Type 4; D001973:Bromodeoxyuridine; D003345:Corticosterone
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):15020-5
9844008
J Neurosci. 1999 Jan 15;19(2):610-8
9880581
J Comp Neurol. 1999 May 3;407(2):287-301
10213096
Pharmacol Biochem Behav. 1999 Sep;64(1):1-5
10494990
J Psychopharmacol. 1999;13(3):274-7
10512083
Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11998-2003
10518565
J Immunol. 2004 Dec 15;173(12):7531-8
15585880
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3034-9
15718284
Curr Opin Cell Biol. 2005 Apr;17(2):129-34
15780588
Psychopharmacology (Berl). 2005 May;179(3):613-9
15672274
Neurosci Biobehav Rev. 2005;29(4-5):571-625
15890404
Biochem J. 2005 Jun 15;388(Pt 3):803-11
15717866
Methods Mol Biol. 2005;307:191-210
15988065
J Immunol. 2005 Aug 1;175(3):1523-31
16034090
J Biol Chem. 2005 Sep 30;280(39):33178-89
16030021
J Clin Invest. 2005 Oct;115(10):2697-9
16200206
Cell. 2005 Oct 7;123(1):25-35
16213210
Drug Discov Today. 2005 Nov 15;10(22):1503-19
16257373
Crit Rev Neurobiol. 1996;10(3-4):419-46
8978989
Eur J Pharmacol. 1997 Mar 5;321(3):273-8
9085037
Br J Pharmacol. 1997 Jun;121(3):459-68
9179387
Eur J Pharmacol. 1997 Jun 5;328(1):9-18
9203561
Science. 2005 Nov 18;310(5751):1187-91
16293762
Hippocampus. 2006;16(3):239-49
16425236
Pharmacol Rep. 2006 Jan-Feb;58(1):115-9
16531638
Circ Res. 2006 Mar 17;98(5):582-4
16543507
Psychopharmacology (Berl). 2006 Jun;186(2):209-17
16586089
Life Sci. 2006 May 30;79(1):81-8
16458932
Proc Natl Acad Sci U S A. 2006 May 23;103(21):8233-8
16702546
Biol Psychiatry. 2006 Jun 15;59(12):1136-43
16797263
Brain Res. 2006 Jun 22;1096(1):104-12
16730340
Stroke. 2006 Aug;37(8):2012-7
16825591
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13208-13
16924103
J Cell Biol. 2006 Nov 6;175(3):441-51
17088426
Biol Psychiatry. 2007 Jan 1;61(1):56-64
16814262
Am J Physiol Cell Physiol. 2007 Jan;292(1):C319-31
16899551
Neuron. 2007 May 3;54(3):387-402
17481393
J Pharmacol Exp Ther. 2007 Aug;322(2):600-9
17519386
Psychopharmacology (Berl). 2007 Jun;192(3):415-24
17333137
Eur J Pharmacol. 1999 Oct 27;383(2):95-106
10585522
Pharmacol Biochem Behav. 2000 Jan 1;65(1):7-13
10638629
J Neurochem. 2000 Mar;74(3):1257-62
10693959
Brain Res. 2000 Apr 7;861(1):117-25
10751571
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6751-6
10841571
Neuropsychopharmacology. 2000 Aug;23(2):198-204
10882846
Synapse. 2000 Aug;37(2):159-62
10881036
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10272-6
10954756
Eur J Pharmacol. 2000 Sep 29;405(1-3):397-406
11033344
Eur Neuropsychopharmacol. 2000 Dec;10(6):473-81
11115737
J Neurosci. 2000 Dec 15;20(24):9040-5
11124980
J Neurosci. 2000 Dec 15;20(24):9104-10
11124987
Indian J Exp Biol. 2000 Jan;38(1):26-30
11233080
Physiol Behav. 2000 Dec;71(5):517-23
11239670
J Chem Neuroanat. 2000 Dec;20(3-4):349-74
11207431
Biochim Biophys Acta. 2001 Mar 19;1518(1-2):27-35
11267656
J Pharmacol Exp Ther. 2001 Nov;299(2):401-7
11602648
J Neurosci. 2002 May 1;22(9):3673-82
11978843
Neuropsychopharmacology. 2002 Oct;27(4):587-95
12377395
Neuropharmacology. 2002 Dec;43(7):1148-57
12504921
J Biol Chem. 2003 Feb 21;278(8):5493-6
12493749
Biochem J. 2003 Mar 1;370(Pt 2):429-38
12441002
Science. 2003 Aug 8;301(5634):805-9
12907793
Neuropsychopharmacology. 2003 Sep;28(9):1562-71
12838272
Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10518-22
12930888
Nat Genet. 2003 Oct;35(2):131-8
14517540
Trends Pharmacol Sci. 2004 Mar;25(3):158-63
15019272
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9468-73
15192151
Neuropsychopharmacology. 2004 Aug;29(8):1432-9
15114341
Science. 1972 Apr 28;176(4033):428-30
4402069
Pharmacol Biochem Behav. 1981 Sep;15(3):501-4
7291252
Methods Find Exp Clin Pharmacol. 1986 Sep;8(9):557-65
2877126
Behav Neural Biol. 1990 Mar;53(2):153-9
2158780
Pharmacol Biochem Behav. 1991 Jun;39(2):321-3
1658815
Mol Cell Biol. 1993 Oct;13(10):6558-71
8413254
Eur Neuropsychopharmacol. 1993 Dec;3(4):477-84
8111220
Gene. 1994 Nov 18;149(2):237-44
7958996
Methods Find Exp Clin Pharmacol. 1994 Dec;16(10):717-21
7723470
Eur J Pharmacol. 1995 Nov 24;286(3):281-90
8608790
Pharmacol Biochem Behav. 1997 Nov;58(3):737-46
9329067
J Psychiatr Res. 1997 Jul-Aug;31(4):393-432
9352470
Braz J Med Biol Res. 1997 Aug;30(8):967-70
9361726
Biochem J. 1997 Dec 1;328 ( Pt 2):549-58
9371714
Biol Psychiatry. 1998 Mar 1;43(5):389-91
9513755
Pharmacol Biochem Behav. 1998 Jul;60(3):645-53
9678648
J Pineal Res. 1998 Aug;25(1):34-40
9694402
Neuropsychopharmacology. 1998 Nov;19(5):381-96
9778660